GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) » Definitions » EV-to-Revenue

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) EV-to-Revenue : 1.47 (As of Jun. 21, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Henan Taloph Pharmaceutical Stock Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Henan Taloph Pharmaceutical Stock Co's enterprise value is ¥2,960 Mil. Henan Taloph Pharmaceutical Stock Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,009 Mil. Therefore, Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue for today is 1.47.

The historical rank and industry rank for Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue or its related term are showing as below:

SHSE:600222' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.33   Med: 2.71   Max: 8.6
Current: 1.47

During the past 13 years, the highest EV-to-Revenue of Henan Taloph Pharmaceutical Stock Co was 8.60. The lowest was 1.33. And the median was 2.71.

SHSE:600222's EV-to-Revenue is ranked better than
66.44% of 1016 companies
in the Drug Manufacturers industry
Industry Median: 2.22 vs SHSE:600222: 1.47

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-21), Henan Taloph Pharmaceutical Stock Co's stock price is ¥4.28. Henan Taloph Pharmaceutical Stock Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.59. Therefore, Henan Taloph Pharmaceutical Stock Co's PS Ratio for today is 1.19.


Henan Taloph Pharmaceutical Stock Co EV-to-Revenue Historical Data

The historical data trend for Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Taloph Pharmaceutical Stock Co EV-to-Revenue Chart

Henan Taloph Pharmaceutical Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.47 2.54 3.60 2.03 1.90

Henan Taloph Pharmaceutical Stock Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 1.85 1.74 1.90 1.79

Competitive Comparison of Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue falls into.



Henan Taloph Pharmaceutical Stock Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2959.952/2008.703
=1.47

Henan Taloph Pharmaceutical Stock Co's current Enterprise Value is ¥2,960 Mil.
Henan Taloph Pharmaceutical Stock Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,009 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Henan Taloph Pharmaceutical Stock Co  (SHSE:600222) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Henan Taloph Pharmaceutical Stock Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.28/3.585
=1.19

Henan Taloph Pharmaceutical Stock Co's share price for today is ¥4.28.
Henan Taloph Pharmaceutical Stock Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.59.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Henan Taloph Pharmaceutical Stock Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Henan Taloph Pharmaceutical Stock Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Jinsuo Road, High-tech Industrial Development Zone, Henan Province, Zhengzhou, CHN, 450001
Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.
Executives
Zhao Qing Xin Director

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Headlines

No Headlines